Willingness to pay for antenatal carrier screening for cystic fibrosis
- 1 November 1995
- journal article
- clinical trial
- Published by Wiley in Health Economics
- Vol. 4 (6) , 439-452
- https://doi.org/10.1002/hec.4730040602
Abstract
We report on a study of women's willingness to pay (WTP) for a cystic fibrosis carrier test by one or other method of service delivery (disclosure or non‐disclosure). The results demonstrate that there was no statistically significant difference in WTP for the methods of testing. Those women who received a negative test result were followed up and asked their WTP for such a result. Values obtained at this stage were 16 per cent higher than those obtained pretest result. Use of prompts, rather than simply asking women to state their WTP, had a statistically significant effect on post‐test result values. The opportunity to terminate the pregnancy, if a test proved positive, was important, but was not the only consideration. This demonstrates the importance to women of other benefits of screening.Keywords
This publication has 23 references indexed in Scilit:
- CONSORT statement: extension to cluster randomised trialsBMJ, 2004
- Contingent Valuation: Is Some Number Better than No Number?Journal of Economic Perspectives, 1994
- The Contingent-valuation MethodMedical Decision Making, 1993
- Ante-natal screening: What constitutes ‘benefit’?Social Science & Medicine, 1993
- A health-economic comparison of diet and drug treatment in obese men with mild hypertensionJournal Of Hypertension, 1992
- Cystic fibrosis: current survival and population estimates to the year 2000.Thorax, 1991
- Costs and Benefits of Prenatal Screening for Cystic FibrosisMedical Care, 1991
- Cystic fibrosis screening and community genetics.Journal of Medical Genetics, 1990
- Value of a negative cervical smearBMJ, 1988
- What Do Patients Value?Medical Care, 1985